Search in:

Drug Design, Development and Therapy Volume 7, 2013 - Issue

Submit an article Journal homepage

Open access

104

Views

CrossRef citations to date

Altmetric

Case Report

Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis

Julien Mahe1 Clinical Pharmacology Department, Institute of Biology, University Hospital, Nantes, FranceCorrespondence[email protected]

Aurélie Meurette2 Clinical Nephrology and Immunology Department, University Hospital, Nantes, France

Anne Moreau3 Laboratory of Pathology, University Hospital, Nantes, France

Caroline Vercel2 Clinical Nephrology and Immunology Department, University Hospital, Nantes, France

Pascale Jolliet1 Clinical Pharmacology Department, Institute of Biology, University Hospital, Nantes, France;4 EA 4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Sciences, University of Nantes, Nantes, France

Pages 723-728 | Published online: 07 Aug 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (25)

Taisuke Irifuku, Kosuke Okimoto, Naoko Masuzawa & Takao Masaki. (2022) Nephrotic-range proteinuria and membranoproliferative glomerulonephritis-like pattern caused by interferon-β1b in a patient with multiple sclerosis. CEN Case Reports.
Crossref

Gabriel Alugba, Alexsandra Urhi, Iyanu Victoria Olateju, Henry Onyemarin, Consolata Uzzi, Tolulope Oshiba-Fowode, Elvis Obomanu, Hakeem Adegboyega Popoola, Emeka J. Okoronkwo, Emmanuel Ukenenye, Gideon Asaolu, Adeolu Funso Oladunjoye & Olubunmi Oladunjoye. (2022) Renal diseases associated with multiple sclerosis: A narrative review. Medicine 101:48, pages e31959.
Crossref

Mohammad Bahadoram, Bijan Keikhaei, Mohammad-Reza Mahmoudian-Sani, Kosar Alikhani & Ammar Helalinasab. (2022) Interferon therapy: Mechanism of renal thrombotic microangiopathy in multiple sclerosis. Revista Colombiana de Reumatología (English Edition) 29:4, pages 434-435.
Crossref

Maxime Dauvergne, David Buob, Cédric Rafat, Marie-Flore Hennino, Mathilde Lemoine, Vincent Audard, Dominique Chauveau, David Ribes, Emilie Cornec-Le Gall, Eric Daugas, Evangéline Pillebout, Vincent Vuiblet, Jean-Jacques Boffa, Isabelle Brocheriou, David Buob, Laurent Daniel, Laurent Doucet, Arnaud François, Viviane Gnemmi, Anissa Moktefi & Vincent Vuiblet. (2021) Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review. Clinical Kidney Journal 14:12, pages 2563-2572.
Crossref

Arwa Nada & Jennifer G Jetton. (2020) Pediatric onco-nephrology: time to spread the word. Pediatric Nephrology 36:8, pages 2227-2255.
Crossref

Reinier Cardentey Sánchez, Amado Díaz Fe, Alejandro Peláez Suarez, Dayme Grass, Teresa Morgado Vega, Armando Sánchez Canal, Dario Siniscalco & María Angeles Robinson Agramonte. (2021) Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis. Drug Development Research 82:5, pages 707-715.
Crossref

Mosè Parisi, Alessia Manni, Francesca Caputo, Maria Trojano & Damiano Paolicelli. (2020) A case report of late‐onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review. Brain and Behavior 11:1.
Crossref

Masoud Mohammad Malekzadeh, Reza Alizadeh, Ziba Aghsaeifard & Mohammad Ali Sahraian. (2020) Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient. Clinical Case Reports 8:6, pages 1061-1064.
Crossref

Babak Soleimani, Katy Murray & David Hunt. (2019) Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis. Drug Safety 42:8, pages 941-956.
Crossref

Ajay Kundra, Mirela Andrei & Jen Chin Wang. 2018. Thrombocytopenia. Thrombocytopenia.

Haiyan Jia, Craig Thelwell, Paula Dilger, Chris Bird, Sarah Daniels & Meenu Wadhwa. (2018) Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy. Thrombosis Research 163, pages 105-116.
Crossref

Ajay Kundra & Jen Chin Wang. (2017) Interferon induced thrombotic microangiopathy (TMA): Analysis and concise review. Critical Reviews in Oncology/Hematology 112, pages 103-112.
Crossref

Haruomi Nishio, Tatsuo Tsukamoto, Takeshi Matsubara, Yoichiro Okada, Ryosuke Takahashi & Motoko Yanagita. (2016) Thrombotic microangiopathy caused by interferon β-1b for multiple sclerosis: a case report. CEN Case Reports 5:2, pages 179-183.
Crossref

I. Azkune Calle, J.L. Sánchez Menoyo, J. Ruiz Ojeda, J.C. García Moncó & I. Etxeguren Urkixo. (2016) Case report of thrombotic microangiopathy associated with subcutaneous interferon beta-1a: An emerging complication?. Neurología (English Edition) 31:7, pages 508-509.
Crossref

I. Azkune Calle, J.L. Sánchez Menoyo, J. Ruiz Ojeda, J.C. García Moncó & I. Etxeguren Urkixo. (2016) Microangiopatía trombótica asociada a interferón beta-1a subcutáneo: ¿una complicación emergente? Descripción de un caso. Neurología 31:7, pages 508-509.
Crossref

Musa Ozturk, Fulya Basoglu, Murvet Yilmaz, Ayse Aysim Ozagari & Sevim Baybas. (2016) Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review. Multiple Sclerosis and Related Disorders 9, pages 50-53.
Crossref

Tatiana Koudriavtseva, Domenico Plantone, Rosaria Renna, Chiara Mandoj, Diana Giannarelli & Caterina Mainero. (2015) Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients. Neurological Sciences 36:12, pages 2263-2268.
Crossref

Hassan Izzedine & Mark A. Perazella. (2015) Thrombotic Microangiopathy, Cancer, and Cancer Drugs. American Journal of Kidney Diseases 66:5, pages 857-868.
Crossref

Sangeetha Murugapandian, Babitha Bijin, Iyad Mansour, Sepehr Daheshpour, Biju G. Pillai, Bijin Thajudeen & Abdulla K. Salahudeen. (2015) Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations. Case Reports in Nephrology and Dialysis 5:2, pages 160-167.
Crossref

Ali-Frédéric Ben-Amor, Anton Trochanov & Tanya Z. Fischer. (2015) Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a. Advances in Therapy 32:5, pages 445-454.
Crossref

Luis F. Quintana & Josep M. Campistol. (2015) Interferón ß, microangiopatía trombótica y síndrome nefrótico. Medicina Clínica 144:2, pages 65-66.
Crossref

Luis F. Quintana & Josep M. Campistol. (2015) Interferon β, nephrotic syndrome and thrombotic microangiopathy. Medicina Clínica (English Edition) 144:2, pages 65-66.
Crossref

Georgina Arrambide. (2014) Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing–remitting multiple sclerosis patients on high-dose interferon beta. Multiple Sclerosis Journal 20:13, pages 1788-1789.
Crossref

. (2013) Interferon-β-1a. Reactions Weekly 1470:1, pages 26-26.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis

Articles from other publishers (25)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis

Citations (25)

Articles from other publishers (25)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date